We are live on ! Find out more
BFRIW icon

Biofrontera

5 hedge funds and large institutions have $1.11M invested in Biofrontera in 2021 Q4 according to their latest regulatory filings, with 5 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
5
Holders Change
+5
Holders Change %
% of All Funds
0.08%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
5
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
BA
1
Bard Associates
Illinois
$756K +$453K +210,100 New
EAM
2
Empery Asset Management
New York
$270K +$162K +75,000 New
WAM
3
Warberg Asset Management
Illinois
$67K +$39.9K +18,487 New
UBS Group
4
UBS Group
Switzerland
$10K +$5.93K +2,750 New
FDCDDQ
5
Federation des caisses Desjardins du Quebec
Quebec, Canada
$4.5K +$2.7K +1,250 New

BFRIW Hedge Fund Activity: Q4 2021 in Review

5 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Biofrontera (BFRIW) for Q4 2021, worth a combined $1.11M.

Buyers outnumbered sellers: 5 funds opened new BFRIW positions and 0 closed out — a net gain of 5 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Bard Associates, opening a new position worth an estimated $453K.

  • 5 institutional investors held Biofrontera (BFRIW) as of Q4 2021, up from 0 in Q3 2021.
  • Funds reported $1.11M of Biofrontera stock for Q4 2021.
  • 5 funds opened new Biofrontera positions in Q4 2021 and 0 closed out, a net change of +5 holders.
  • The largest Biofrontera buyer in Q4 2021 was Bard Associates, an estimated $453K added.

Based on aggregated 13F filings for Q4 2021.